PMLive3d
Merck KGaA’s Mavenclad tablets recommended by NICE for wider MS use
Merck KGaA’s Mavenclad (cladribine) tablets have been recommended by the National Institute for Health and Care Excellence ...
pharmaphorum3d
Merck MS tablet set for wider use by NHS in England
The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...
Take-at-home tablet for MS approved for wider NHS rollout
A take-at-home tablet for multiple sclerosis (MS) is set to be more broadly rolled out on the NHS, potentially benefiting ...
Medical Marketing & Media5d
Selma Blair collabs with EMD Serono for DTC campaign about relapsing MS
The Merck KGaA collaborated with actress and patient advocate Selma Blair for the I’m Ready campaign. When EMD Serono embarked on a campaign to empower patients living with relapsing multiple ...
pharmaphorum2d
UK PM Keir Starmer plans to abolish NHS England
Just days after announcing sweeping job cuts at NHS England, UK Prime Minister Keir Starmer has said that the government ...
ITV3d
Take-at-home tablet for MS approved by NHS
The health service is thought to be the first in Europe to widely rollout cladribine, also known as Mavenclad and made by Merck. It has been approved by the National Institute for Health and Care ...
Express & Star4d
Take-at-home tablet for MS approved for wider NHS rollout
The health service is thought to be the first in Europe to widely rollout cladribine, also known as Mavenclad and made by Merck. It has been approved by the National Institute for Health and Care ...